The FDA amended emergency authorization of Johnson & Johnson's Covid-19 vaccine. In other regulatory news this past week, drug approvals include a cancer drug that converted its accelerated regulatory approval to a full regulatory nod, while several companies dealt with rejections or clinical trial setbacks.
MedCity INVEST PharmaTech 2022 is a program dedicated to exploring the next chapter of the biopharma industry. Discussions will explore how pharma companies leverage digital innovations to achieve greater success and transform the lives of patients.
Cell and gene therapy research has been hot the past few years but the overall market has cooled down in recent months. During the World Medical Innovation Forum in Boston, a panel of venture capitalists discussed capital formation and what biotech firms need to do to win over investors and advance their research.
By Dietrich A. Stephan Sunday, May 8, 2022 4:00 PM
The model of investing huge amounts of money into one drug to try to recoup it later is problematic at best and unsustainable at worst. Platform technology provides a better, more cost-effective way forward.
Artificial intelligence can help drug study teams solve operational, scientific and ethical challenges. For example, AI can be used to flag real-time trends emerging in drug trials that might otherwise not be obvious until the end of a study when all the data is analyzed.
By Brian Covino and Matt Murphy Sunday, May 8, 2022 9:00 AM
An intelligent authorization platform relies on AI and machine learning to extract patient-specific data from a number of sources including the EHR. This helps health plans better anticipate, manage and optimize member outcomes.
No comments